Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California 94143, USA.
J Neurosurg. 2010 Jan;112(1):1-9. doi: 10.3171/2009.6.JNS0952.
Insular gliomas remain surgically challenging cases due to complex anatomy, including surrounding vasculature and the relationship to functional structures. To define the morbidity profile associated with aggressive insular glioma removal as well as its impact on long-term outcome, the authors retrospectively evaluated the extent of resection (EOR) in the context of this complex anatomy and function and assessed its role in determining disease progression, malignant transformation, and, ultimately, patient survival.
The study population included adults who had undergone initial or repeat resection of insular gliomas of all grades. Tumor location was identified according to a proposed quadrant-style classification (Zones I-IV) of the insula. Low- and high-grade gliomas were volumetrically analyzed using FLAIR and contrast-enhanced T1-weighted MR imaging, respectively.
One hundred fifteen procedures involving 104 patients with insular gliomas were identified. Patients presented with low-grade gliomas (LGGs) in 70 cases (60%) and high-grade gliomas (HGGs) in 45 (40%). Zone I (anterior-superior) was the most common site within the insula (40 patients [39%]), followed by Zone I+IV (anterior-superior + anterior-inferior; 26 patients [25%]). The median EOR was 82% (range 31-100%) for low-grade lesions and 81% (range 47-100%) for high-grade lesions. Zone I was associated with the highest median EOR (86%), and among all lesion grades, the insular quadrant anatomy was predictive of the EOR (p = 0.0313). Overall, there were 16 deaths (15%) during a median follow-up of 4.2 years. There were no surgery-related deaths, and new, permanent postoperative deficits were noted in 6 patients (6%). Among LGGs, tumor progression and malignant transformation were identified in 20 (29%) and 14 cases (20%), respectively. Among HGGs, progression was identified in 16 cases (36%). Patients with LGGs resected >or= 90% had a 5-year overall survival (OS) rate of 100%, whereas those with lesions resected < 90% had a 5-year OS rate of 84%. Patients with HGGs resected >or= 90% had a 2-year OS rate of 91%; when the EOR was < 90%, the 2-year OS rate was 75%. The EOR was predictive of OS both in cases of LGGs (hazard ratio [HR] 0.955, 95% CI 0.921-0.992, p = 0.017) and HGGs (HR 0.955, 95% CI 0.918-0.994, p = 0.024). Progression-free survival (PFS) was also predicted by the EOR in both LGGs (HR 0.973, 95% CI 0.948-0.998, p = 0.0414) and HGGs (HR 0.958, 95% CI 0.919-0.999, p = 0.0475). Interestingly, among patients with LGGs, malignant progression was also significantly associated with a lower EOR (HR 0.968, 95% CI 0.393-0.998, p = 0.0369).
Aggressive resection of insular gliomas of all grades can be accomplished with an acceptable morbidity profile and is predictive of improved OS and PFS. Among insular LGGs, a greater EOR is also associated with longer malignant PFS. Data in this study also suggest that insular gliomas generally follow a more indolent course than similar lesions in other brain regions.
由于其复杂的解剖结构,包括周围的血管和与功能结构的关系,岛叶胶质瘤的手术仍然具有挑战性。为了明确与侵袭性岛叶胶质瘤切除相关的发病率,并评估其对长期预后的影响,作者回顾性评估了在这种复杂解剖和功能背景下的最大切除程度(EOR),并评估了其在确定疾病进展、恶性转化以及最终患者生存方面的作用。
研究人群包括接受初始或再次切除所有级别岛叶胶质瘤的成年人。根据岛叶的四象限(Ⅰ-Ⅳ区)分区法确定肿瘤位置。使用 FLAIR 和对比增强 T1 加权 MR 成像分别对低级别和高级别胶质瘤进行体积分析。
共发现 115 例 104 名岛叶胶质瘤患者的 115 例手术。患者表现为低级别胶质瘤(LGG)70 例(60%)和高级别胶质瘤(HGG)45 例(40%)。Ⅰ区(前上)是岛叶最常见的部位(40 例[39%]),其次是Ⅰ+Ⅳ区(前上+前下)(26 例[25%])。低级别病变的中位 EOR 为 82%(范围 31-100%),高级别病变为 81%(范围 47-100%)。Ⅰ区的中位 EOR 最高(86%),在所有病变分级中,岛叶象限解剖结构与 EOR 相关(p=0.0313)。总的来说,中位随访 4.2 年后有 16 例(15%)死亡。无手术相关死亡,6 例(6%)患者出现新的永久性术后缺陷。在 LGG 中,20 例(29%)和 14 例(20%)分别发现肿瘤进展和恶性转化。在 HGG 中,16 例(36%)发现进展。切除>90%的 LGG 患者 5 年总生存率(OS)为 100%,而切除<90%的患者 5 年 OS 率为 84%。切除>90%的 HGG 患者 2 年 OS 率为 91%;当 EOR<90%时,2 年 OS 率为 75%。EOR 在 LGG(风险比[HR]0.955,95%CI0.921-0.992,p=0.017)和 HGG(HR0.955,95%CI0.918-0.994,p=0.024)中均预测 OS。在 LGG(HR0.973,95%CI0.948-0.998,p=0.0414)和 HGG(HR0.958,95%CI0.919-0.999,p=0.0475)中,无进展生存期(PFS)也可通过 EOR 预测。有趣的是,在 LGG 患者中,恶性进展也与较低的 EOR 显著相关(HR0.968,95%CI0.393-0.998,p=0.0369)。
所有级别岛叶胶质瘤的侵袭性切除可以达到可接受的发病率,并预测更好的 OS 和 PFS。在岛叶 LGG 中,更大的 EOR 也与更长的恶性 PFS 相关。本研究的数据还表明,岛叶胶质瘤通常比其他脑区的类似病变具有更惰性的病程。